Publication | Open Access
Randomised clinical trial: tegoprazan, a novel potassium‐competitive acid blocker, or lansoprazole in the treatment of gastric ulcer
78
Citations
9
References
2020
Year
Tegoprazan 50 or 100 mg were not inferior to lansoprazole 30 mg once daily in the treatment of gastric ulcers.
| Year | Citations | |
|---|---|---|
Page 1
Page 1